Skip to content
Trial Eligibility
Menu

Breast Cancer Clinical Trials near New York, NY

239 studies for Breast Cancer are recruiting at 979 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Breast Cancer trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Breast Cancer studies enrolling near New York

Showing the 50 nearest of 239 studies.
  1. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    NCT05879926

    • Phase 3
    • Ages 18 to 60 years
    • Sex: Female

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Lenox Hill Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    45 sites within 50 mi
  2. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

    NCT05812807

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Lenox Hill Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    43 sites within 50 mi
  3. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    NCT04852887

    • Phase 3
    • Ages 50 to 70 years
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Lenox Hill Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    33 sites within 50 mi
  4. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    NCT06058377

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Lenox Hill Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    32 sites within 50 mi
  5. Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

    NCT05929768

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Manhattan Eye Ear and Throat Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  6. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    NCT06876714

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY); NYP/Weill Cornell Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    19 sites within 50 mi
  7. E-Mindfulness Approaches for Living After Breast Cancer

    NCT06748222

    • Phase 3
    • Ages 18 to 50 years
    • Sex: All

    Nearest sites: Mount Sinai Chelsea (New York, NY); Mount Sinai Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    18 sites within 50 mi
  8. ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

    NCT07173751

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Paradigm New York Cancer and Blood Specialists (New York, NY); Paradigm New York Cancer and Blood Specialists (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    17 sites within 50 mi
  9. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    NCT05564377

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    16 sites within 50 mi
  10. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    NCT06418204

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY); Queens Hospital Center (Jamaica, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  11. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  12. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    NCT06492616

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Columbia University Medical Center (New York, NY); Icahn School of Medicine Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  13. A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

    NCT06827236

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Beth Israel Comprehensive Cancer Center (New York, NY); Icahn School of Medicine at Mount Sinai PRIME (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    12 sites within 50 mi
  14. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY); Queens Hospital Center (Jamaica, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  15. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

    NCT05633654

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Canter (New York, NY); Northwell Health (Lake Success, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  16. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    NCT07391774

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); Mount Sinai Chelsea (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  17. Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

    NCT03808337

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  18. Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

    NCT04084730

    • Phase 2
    • Ages 45 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  19. ATEMPT 2.0: Adjuvant T-DM1 vs TH

    NCT04893109

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: New York University Langone Health (New York, NY); Northwell University (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  20. A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

    NCT05570253

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Hackensack Meridian Health (Hackensack, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  21. A Study of Language Interpretation Solutions for People With Breast Cancer

    NCT06721065

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering at Ralph Lauren Center (All Protocol Activities) (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  22. Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

    NCT00823654

    • Observational
    • Ages 18 to 44 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  23. Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

    NCT01788839

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  24. Lymphedema Surveillance Study

    NCT02743858

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Consent only) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  25. Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job

    NCT03572374

    • Interventional
    • Ages 18 to 64 years
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Queens Cancer Center of Queens Hospital (Jamaica, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  26. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    NCT03723928

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mount Sinai Chelsea (New York, NY); Mount Sinai Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  27. A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

    NCT04683679

    • Phase 2
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (All Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  28. A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

    NCT05412225

    • Phase 1
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  29. A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

    NCT05534438

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  30. Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

    NCT05590949

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  31. Study of Aerobic Training for People Receiving Treatment for Breast Cancer

    NCT05716893

    • Phase 2
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited protocol activities) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  32. A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

    NCT05837767

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited protocol activities) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  33. A Study of Blood Pressure Control During Cancer Treatment

    NCT06023576

    • Phase 2
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  34. Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

    NCT06072612

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Manhattan Hematology /Oncology Associates (New York, NY); New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C (NY) (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  35. A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

    NCT06099769

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  36. A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

    NCT06144164

    • Phase 3
    • Ages 18 to 75 years
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  37. A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

    NCT06246968

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All protocol activites) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activites) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  38. A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)

    NCT06334354

    • Observational
    • Ages 60 to 80 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (All Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  39. A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

    NCT06623396

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  40. A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

    NCT06678269

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All protocol activites) (New York, NY); Memorial Sloan Kettering Nassau (All protocol activities) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  41. Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

    NCT06728579

    • Phase 2
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (All Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  42. A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

    NCT06790693

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  43. MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

    NCT06954337

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activites) (New York, NY); Memorial Sloan Kettering Nassau (All Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  44. A Study of Revaree Plus in People With Breast Cancer

    NCT07042581

    • Phase 4
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Consent Only) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  45. A Study of Surgery and Radiotherapy in People With Breast Cancer

    NCT07053085

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All protocol activites) (New York, NY); Memorial Sloan Kettering Nassau (Limited protocol activities) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  46. A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

    NCT07218250

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Consent Only) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  47. A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

    NCT07220967

    • Phase 4
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activites) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activites) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  48. Factors Associated With Breast Cancer Risks and Outcomes

    NCT07294703

    • Observational
    • Ages 18 years and older
    • Sex: Female

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activites) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activites) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  49. Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

    NCT07308717

    • Phase 4
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  50. A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

    NCT07335354

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Breast Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.